Berna Beverloo

1.3k citations
22 papers · 477 · h-index 11

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
  • Ophthalmology top 5%
    • Ocular Oncology and Treatments

Papers in

  • Hematology 10
    • Acute Myeloid Leukemia Research 6
    • Multiple Myeloma Research and Treatments 5
    • Chronic Myeloid Leukemia Treatments 3
  • Molecular Biology 6
    • Protein Degradation and Inhibitors 2
Co-authors
Erik Forestier (1 shared paper)Andrea Pession (1 shared paper)Marry M. van den Heuvel‐Eibrink (2 shared papers)Bertil Johansson (1 shared paper)Christopher A. French (1 shared paper)Oskar A. Haas (2 shared papers)Cees A. Meeuwis (1 shared paper)K Michalová (1 shared paper)
Journals
Blood (7 papers)HemaSphere (2 papers)Investigative Ophthalmology & Visual Science (2 papers)British Journal of Haematology (1 paper)American Journal Of Pathology (1 paper)
Partner nations
NetherlandsItalyGermany

In The Last Decade

Berna Beverloo

19 papers receiving 462 citations

Peers

Berna Beverloo
Comparison fields: 5 of 38
  • Hematology 142
  • Ophthalmology 57
  • Public Health, Environmental and Occupational Health 101
  • Molecular Biology 231
  • Oncology 81
Replace Midori Saito with:
Midori Saito Japan
Angela Douglas United Kingdom
Emel Bayar United States
Mineo Kurokawa Japan
BH Kushner United States
Lesley Everett United States
Guillaume Sarrabay France
N Bown United Kingdom
Cristina Robledo Spain
E. L. Prigogina United States
Berna Beverloo relative to Midori Saito Japan Midori Saito's profile →
Citations per field
00.5×5×11.5×
Midori Saito · 1×
Citations per year

Countries citing papers authored by Berna Beverloo

Since Specialization
Citations

This map shows the geographic impact of Berna Beverloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berna Beverloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berna Beverloo more than expected).

Fields of papers citing papers by Berna Beverloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berna Beverloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berna Beverloo. The network helps show where Berna Beverloo may publish in the future.

Co-authors

The 25 scholars most cited alongside Berna Beverloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Berna Beverloo Line = papers co-authored together Berna Beverloo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
Blood ·Erik Forestier, Shai Izraeli, Berna Beverloo, Oskar A. Haas, Andrea Pession, K Michalová, Batia Stark, Christine J. Harrison, Andrea Teigler‐Schlegel, Bertil Johansson
2007105
2
Restricted 12p Amplification and RAS Mutation in Human Germ Cell Tumors of the Adult Testis
American Journal Of Pathology ·Helene Roelofs, Marijke Mostert, K. Pompe, Gaetano Zafarana, Monique van Oorschot, Ruud J. H. L. M. van Gurp, Ad Gillis, Hans Stoop, Berna Beverloo, J. Wolter Oosterhuis, Carsten Bokemeyer, Leendert H. J. Looijenga
200091
3
NUT Midline Carcinoma of the Parotid Gland With Mesenchymal Differentiation
The American Journal of Surgical Pathology ·Michael A. den Bakker, Berna Beverloo, Marry M. van den Heuvel‐Eibrink, Cees A. Meeuwis, Liane M. Tan, Laura A. Johnson, Christopher A. French, Geert J.L.H. van Leenders
200985
4
Mistaken Identity of Widely Used Esophageal Adenocarcinoma Cell Line TE-7
Cancer Research ·Jurjen J. Boonstra, Albertina W. van der Velden, Erwin C.W. Beerens, Ronald van Marion, Yuiko Morita‐Fujimura, Yasuhisa Matsui, T Nishihira, Chris Tselepis, Pierre Hainaut, Anson W. Lowe, Berna Beverloo, Herman van Dekken, Hugo W. Tilanus, Winand N.M. Dinjens
200741
5
Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma
Ophthalmology ·Serdar Yavuzyiğitoğlu, Wojtek Drabarek, Kyra N. Smit, Natasha M. van Poppelen, Anna E. Koopmans, Jolanda Vaarwater, Tom Brands, Bert Eussen, Hendrikus J. Dubbink, Job van Riet, Harmen J.G. van de Werken, Berna Beverloo, Robert M. Verdijk, Nicole C. Naus, (unknown), Emine Kılıç, Annelies de Klein
201625
6
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23
Genes Chromosomes and Cancer ·Lucienne Michaux, Iwona Włodarska, Michel Stul, Judith Dierlamm, Francine Mugneret, Christian Herens, Berna Beverloo, Alain Verhest, Christine Verellen‐Dumoulin, Gregor Verhoef, Dominik Selleslag, V. Madoe, Marianne Lecomte, Bernard Deprijck, Augustin Ferrant, André Delannoy, Sabine Marichal, Caroline Duhem, Mario Dicato, Anne Hagemeijer
200021
7
Generation of a tightly regulated doxycycline‐inducible model for studying mouse intestinal biology
genesis ·Sabrina Roth, Patrick Franken, Wendy van Veelen, Lau Blonden, Lalini Raghoebir, Berna Beverloo, Ellen van Drunen, Ernst J. Kuipers, Robbert J. Rottier, Riccardo Fodde, Ron Smits
200820
8
CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B‐ and T‐cell origin but is frequent in acute lymphoblastic leukaemia
British Journal of Haematology ·Martin Schröder, U. Mathieu, Martin Dreyling, Stefan K. Bohlander, Anne Hagemeijer, Berna Beverloo, Olufunmilayo I. Olopade, Stephan Stilgenbauer, Konstanze Fischer, Martin Bentz, Peter Lichter, Hartmut Döhner
199517
9
Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8
Melanoma Research ·Walter van Gils, Emine Kılıç, Hennie T. Brüggenwirth, Jolanda Vaarwater, Michaël Verbiest, Berna Beverloo, Marjan E. van Til-Berg, (unknown), Gregorius P. M. Luyten, Annelies de Klein
200817
10
Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated WithBAP1Mutations
Investigative Ophthalmology & Visual Science ·Serdar Yavuzyiğitoğlu, Hanneke W. Mensink, Kyra N. Smit, Jolanda Vaarwater, Robert M. Verdijk, Berna Beverloo, Hennie T. Brüggenwirth, Ronald van Marion, Hendrikus J. Dubbink, (unknown), Nicole C. Naus, Annelies de Klein, Emine Kılıç
201616
11
Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma
Investigative Ophthalmology & Visual Science ·Daniël P. de Bruyn, Natasha M. van Poppelen, Tom Brands, Susanne C. van den Boom, Ellis L. Eikenboom, Anja Wagner, Monique M. van Veghel–Plandsoen, Geert Geeven, Berna Beverloo, Caroline M. van Rij, Robert M. Verdijk, Nicole C. Naus, Mette Bagger, Jens Folke Kiilgaard, Annelies de Klein, Erwin Brosens, Emine Kılıç
202410
12
NUP98/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias
Leukemia Research ·Barbara Crescenzi, Valeria Nofrini, Gianluca Barba, Caterina Matteucci, Danika Di Giacomo, Paolo Gorello, Berna Beverloo, Antonella Vitale, Iwona Włodarska, Peter Vandenberghe, Roberta La Starza, Cristina Mecucci
201510
13
Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA
Oncotarget ·Katarzyna Kluzek, Malgorzata I. Srebniak, Weronika Majer, Agnieszka Ida, Tomasz Milecki, Kinga Humińska‐Lisowska, R.M. van der Helm, Adrian Silesian, Tomasz Wrzesiński, Jacek Wojciechowicz, Berna Beverloo, Zbigniew Kwias, Hans A.R. Bluyssen, Joanna Wesoły
20179
14
Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.
Blood ·Brian V. Balgobind, Marry M. van den Heuvel‐Eibrink, Renée X. de Menezes, Dirk Reinhardt, Iris H.I.M. Hollink, Susan T.J.C.M. Arentsen-Peters, Elisabeth R. van Wering, Gertjan J.L. Kaspers, Jaqueline Cloos, Eveline S.J.M. de Bont, André Baruchel, Jean‐Michel Cayuela, Jan Starý, Jan Trka, Berna Beverloo, Rob Pieters, C. Michel Zwaan, Monique L. den Boer
20082
15
Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene
Blood Advances ·Taco W. Kuijpers, Andrica C. H. de Vries, Ester M. van Leeuwen, Anton A. M. Ermens, S. de Pont, Desirée E.C. Smith, Mirjam M. C. Wamelink, Arjen R. Mensenkamp, Marcel Nelen, Hana Lango Allen, Steven T. Pals, Berna Beverloo, Hidde H. Huidekoper, Anja Wagner
20222
16
Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
Blood ·Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta Fiocco, Vincent H. J. van der Velden, Berna Beverloo, Marc Bierings, Válerie de Haas, Peter M. Hoogerbrugge, Inge M. van der Sluis, Wim J. E. Tissing, Margreet A. Veening, Judith M. Boer, Monique L. den Boer
20222
17
Chromosome 14 Copy Number-Dependent IGH Gene Rearrangement Patterns in High Hyperdiploid Childhood B Cell Precursor ALL: Implications for Leukemia Biology and Minimal Residual Disease Analysis.
Blood ·Eva Csinady, Vincent van der Velden, Ulrike Kaindl, Ruth Joas, Jelteje de Vries, Berna Beverloo, Jacques J. M. van Dongen, Georg Mann, Oskar A. Haas, Renate Panzer‐Grümayer
20081
18
High Incidence of t(7;12)(q36;p13) with Involvement of HLXB9 in Infant AML.
Blood ·Anne R. M. von Bergh, Ellen van Drunen, Elisabeth R. van Wering, Jules P.P. Meijerink, Rob Pieters, Berna Beverloo
20051
19
Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)
Blood ·Meral Beksaç, Tülin Tuğlular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Ekrem Ünal, Michèle Cavo, Güner Hayri Özsan, Vincent H. J. van der Velden, Berna Beverloo, Michael Vermeulen, Mark van Duin, Güldane Cengiz Seval, Ömür Gökmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
20221
20
Combining Plasma Cell Leukemia-like Status with the Second Revision of the International Staging System Improves Risk Classification
Blood ·Davine Hofste op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H. J. van der Velden, Remco M. Hoogenboezem, Bronno van der Holt, Berna Beverloo, Erik T. Valent, Michael Vermeulen, Mattia D’Agostino, Francesca Gay, Annemiek Broijl, Hervé Avet‐Loiseau, Nikhil C. Munshi, Pellegrino Musto, Philippe Moreau, Sonja Zweegman, Niels W.C.J. van de Donk, Pieter Sonneveld
20221

About Berna Beverloo

Berna Beverloo is a scholar working on Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Oncology, having authored 22 papers that have together received 477 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Genomic variations and chromosomal abnormalities (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Ocular Oncology and Treatments (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (142 citations), Ophthalmology (57 citations), Public Health, Environmental and Occupational Health (101 citations), Molecular Biology (231 citations) and Oncology (81 citations). Berna Beverloo has collaborated with scholars based in Netherlands, Italy and Germany. Frequent co-authors include Erik Forestier, Andrea Pession, Marry M. van den Heuvel‐Eibrink, Bertil Johansson, Christopher A. French, Oskar A. Haas, Cees A. Meeuwis, K Michalová, Michael A. den Bakker and Christine J. Harrison. Their work appears in journals such as Blood, HemaSphere, Investigative Ophthalmology & Visual Science, British Journal of Haematology and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Midori SaitoBreakdown of academic impact, for papers by Angela DouglasBreakdown of academic impact, for papers by Emel BayarBreakdown of academic impact, for papers by Mineo KurokawaBreakdown of academic impact, for papers by BH KushnerBreakdown of academic impact, for papers by Lesley EverettBreakdown of academic impact, for papers by Guillaume SarrabayBreakdown of academic impact, for papers by N BownBreakdown of academic impact, for papers by Cristina RobledoBreakdown of academic impact, for papers by E. L. Prigogina